Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 327, doi. 10.1038/sj.bmt.1705439
- By:
- Publication type:
- Article
Works matching IS 02683369 AND DT 2006 AND VI 38 AND IP 5
Results: 16
1
2
Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 377, doi. 10.1038/sj.bmt.1705444
- By:
- Publication type:
- Article
3
Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 351, doi. 10.1038/sj.bmt.1705446
- By:
- Publication type:
- Article
4
Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 339, doi. 10.1038/sj.bmt.1705447
- By:
- Publication type:
- Article
5
Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 359, doi. 10.1038/sj.bmt.1705449
- By:
- Publication type:
- Article
6
Muromonab-CD3 (Orthoclone OKT3<sup>®</sup>), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 365, doi. 10.1038/sj.bmt.1705450
- By:
- Publication type:
- Article
7
Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
- Published in:
- 2006
- By:
- Publication type:
- Letter
8
Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 371, doi. 10.1038/sj.bmt.1705453
- By:
- Publication type:
- Article
9
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation.
- Published in:
- 2006
- By:
- Publication type:
- Letter
10
Allogeneic stem cell transplantation from donors with mosaic Turner syndrome.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 385, doi. 10.1038/sj.bmt.1705456
- By:
- Publication type:
- Article
11
Severe intestinal graft-versus-host disease following autologous stem cell transplantation.
- Published in:
- 2006
- By:
- Publication type:
- Letter
12
Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells.
- Published in:
- 2006
- By:
- Publication type:
- Letter
13
Interferon-α after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 5, p. 345, doi. 10.1038/sj.bmt.1705458
- By:
- Publication type:
- Article
14
An assessment of the RIFLE criteria for acute renal failure following myeloablative autologous and allogeneic haematopoietic cell transplantation.
- Published in:
- 2006
- By:
- Publication type:
- Letter
15
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2006
- By:
- Publication type:
- Correction Notice
16
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
- Published in:
- 2006
- By:
- Publication type:
- Correction Notice